New Nordic Healthbrands AB (publ)
Символ: NNH.ST
STO
19.6
SEKПазарна цена днес
-20.0006
Съотношение P/E
0.0280
Коефициент PEG
121.43M
MRK Cap
- 0.00%
Доходност на DIV
New Nordic Healthbrands AB (publ) (NNH-ST) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 55.53 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 452.39 | 101.9 | 116.5 | 97 | ||||||||||||||||
balance-sheet.row.inventory | 395.85 | 105.1 | 110.2 | 116.5 | ||||||||||||||||
balance-sheet.row.other-current-assets | 33.73 | 9.1 | 0 | 2.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 937.51 | 230 | 237.3 | 228.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 15.32 | 4.4 | 3.2 | 2.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 11.5 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 11.5 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 8.27 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 2.88 | 10.2 | 7 | 4.2 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 13.97 | 3.1 | -7 | 0 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 66.7 | 19.1 | 14.3 | 10.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1004.2 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.account-payables | 318.63 | 86.4 | 66.5 | 66 | ||||||||||||||||
balance-sheet.row.short-term-debt | 140.28 | 26.6 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.tax-payables | 7.91 | 2 | 1.7 | 3.6 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 7.63 | 2.2 | 1.6 | 0 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.67 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 125.4 | 25.3 | 22.6 | 7.6 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 8.29 | 2.8 | 1.6 | 3.4 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-liab | 556.5 | 143 | 139.1 | 118 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 24.78 | 6.2 | 6.2 | 6.2 | ||||||||||||||||
balance-sheet.row.retained-earnings | 300.07 | 96.8 | 106.4 | 114.1 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 422.92 | 99.8 | 106.4 | 0.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -300.07 | -96.8 | -106.4 | -0.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 447.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1004.2 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 447.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1004.2 | - | - | - | ||||||||||||||||
Total Investments | 16.93 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.total-debt | 147.91 | 28.8 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.net-debt | 92.37 | 15 | 37.6 | 12.5 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2.98 | -6.2 | -4.7 | 28.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 1.89 | 1.2 | 1.6 | 0.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 31.68 | 31.7 | -3.4 | -31.1 | ||||||||||||||||
cash-flows.row.account-receivables | 2.75 | 2.8 | -10.4 | -4.6 | ||||||||||||||||
cash-flows.row.inventory | 4.92 | 4.9 | 6.3 | -35.8 | ||||||||||||||||
cash-flows.row.account-payables | 24.01 | 24 | 0.8 | 9.3 | ||||||||||||||||
cash-flows.row.other-working-capital | -6.1 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -12.97 | 1.3 | -9 | -6.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 28.03 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -3.07 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | -0.33 | -0.3 | 0 | -0.3 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3.4 | -3.4 | -2.6 | -3 | ||||||||||||||||
cash-flows.row.debt-repayment | -21.18 | -21.2 | -24.3 | -22.9 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -7.7 | -9.3 | ||||||||||||||||
cash-flows.row.other-financing-activites | -12.09 | 0 | 48.7 | 44.2 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -21.17 | -21.2 | 16.6 | 12.1 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.35 | -0.3 | 0.3 | 0.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 3.11 | 3.1 | -1.2 | 1.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 55.53 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 52.42 | 10.7 | 11.9 | 10.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 28.03 | 28 | -15.5 | -7.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -3.07 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 24.96 | 25 | -18.4 | -10.6 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 533.85 | 533.8 | 487.5 | 514.8 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 283.64 | 536.3 | 169 | 164.8 | ||||||||||||||||
income-statement-row.row.gross-profit | 250.21 | -2.5 | 318.5 | 350 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0.67 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 199.7 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 17.05 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 351.39 | 0.7 | 323.2 | 321.5 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 537.01 | 537 | 492.3 | 486.3 | ||||||||||||||||
income-statement-row.row.interest-income | 0.82 | 0.1 | 0 | 0 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.83 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.75 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 17.05 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.75 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.83 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1.89 | 1.2 | 2.8 | 0.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -1.26 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -3.17 | -3.2 | -4.7 | 28.5 | ||||||||||||||||
income-statement-row.row.income-before-tax | -5.91 | -5.9 | -5.2 | 28 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0.28 | 0.3 | -2.3 | 6.7 | ||||||||||||||||
income-statement-row.row.net-income | -6.2 | -6.2 | -2.8 | 21.3 |
Често задавани въпроси
Какво е New Nordic Healthbrands AB (publ) (NNH.ST) общи активи?
New Nordic Healthbrands AB (publ) (NNH.ST) общите активи са 249060000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 277667000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 4.029.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 4.029.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.012.
Какъв е общият приход на предприятието?
Общият приход е -0.006.
Каква е New Nordic Healthbrands AB (publ) (NNH.ST) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -6194000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 28824000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 672000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 13813000.000.